2017 Sec 1 Green Book

Allergy Asthma Immunol . 2008;101(4): 431 – 436 95. Weinstein S, Qaqundah P, Georges G, Nayak A. Ef fi cacy and safety of tri- amcinolone acetonide aqueous nasal spray in children aged 2 to 5 years with perennial allergic rhinitis: a randomized, double-blind, placebo-controlled study with an open-label extension. Ann Allergy Asthma Immunol . 2009;102(4):339 – 347 96. Zitt M, Kosoglou T, Hubbell J. Mometasone furoate nasal spray: a review of safety and systemic effects. Drug Saf . 2007;30(4): 317 – 326 97. Adam P, Stiffman M, Blake RL Jr. A clinical trial of hypertonic saline nasal spray in subjects with the common cold or rhino- sinusitis. Arch Fam Med . 1998;7(1):39 – 43 98. Wang YH, Yang CP, Ku MS, Sun HL, Lue KH. Ef fi cacy of nasal irrigation in the treat- ment of acute sinusitis in children. Int J Pediatr Otorhinolaryngol . 2009;73(12): 1696 – 1701 99. Harvey R, Hannan SA, Badia L, Scadding G. Nasal saline irrigations for the symptoms of chronic rhinosinusitis. Cochrane Data- base Syst Rev . 2007;(3):CD006394 100. Kassel JC, King D, Spurling GK. Saline na- sal irrigation for acute upper respiratory tract infections. Cochrane Database Syst Rev . 2010;(3):CD006821 101. Shapiro GG, Virant FS, Furukawa CT, Pier- son WE, Bierman CW. Immunologic defects in patients with refractory sinusitis. Pe- diatrics . 1991;87(3):311 – 316 102. Wood AJ, Douglas RG. Pathogenesis and treatment of chronic rhinosinusitis. Post- grad Med J . 2010;86(1016):359 – 364 103. Liao S, Durand ML, Cunningham MJ. Sinogenic orbital and subperiosteal ab- scesses: microbiology and methicillin- resistant Staphylococcus aureus in- cidence. Otolaryngol Head Neck Surg . 2010;143(3):392 – 396 104. Oxford LE, McClay J. Medical and surgical management of subperiosteal orbital ab- scess secondary to acute sinusitis in children. Int J Pediatr Otorhinolaryngol . 2006;70(11):1853 – 1861

76. Lynch JP, III, Zhanel GG. Streptococcus pneumoniae : epidemiology and risk fac- tors, evolution of antimicrobial resistance, and impact of vaccines. Curr Opin Pulm Med . 2010;16(3):217 – 225 77. Sahm DF, Jones ME, Hickey ML, Diakun DR, Mani SV, Thornsberry C. Resistance sur- veillance of Streptococcus pneumoniae, Haemophilus in fl uenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998. J Antimicrob Chemother . 2000; 45(4):457 – 466 78. Sokol W. Epidemiology of sinusitis in the primary care setting: results from the 1999-2000 respiratory surveillance pro- gram. Am J Med . 2001;111(suppl 9A):19S – 24S 79. Shaikh N, Wald ER, Pi M. Decongestants, antihistamines and nasal irrigation for acute sinusitis in children. Cochrane Da- tabase Syst Rev . 2010;(12):CD007909 80. Dolor RJ, Witsell DL, Hellkamp AS, Williams JW, Jr, Califf RM, Simel DL. Comparison of cefuroxime with or without intranasal fl u- ticasone for the treatment of rhinosinusitis. The CAFFS Trial: a randomized controlled trial. JAMA . 2001;286(24):3097 – 3105 81. Meltzer EO, Bachert C, Staudinger H. Treating acute rhinosinusitis: comparing ef fi cacy and safety of mometasone furo- ate nasal spray, amoxicillin, and placebo. J Allergy Clin Immunol . 2005;116(6):1289 – 1295 82. Meltzer EO, Charous BL, Busse WW, Zinreich SJ, Lorber RR, Danzig MR. Added relief in the treatment of acute recurrent sinusitis with adjunctive mometasone furoate nasal spray. The Nasonex Sinusitis Group. J Allergy Clin Immunol . 2000;106 (4):630 – 637 83. Meltzer EO, Orgel HA, Backhaus JW, et al. Intranasal fl unisolide spray as an adjunct to oral antibiotic therapy for sinusitis. J Allergy Clin Immunol . 1993;92(6):812 – 823 84. Nayak AS, Settipane GA, Pedinoff A, et al. Effective dose range of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Ann Allergy Asthma Immunol . 2002;89(3):271 – 278

85. Williamson IG, Rumsby K, Benge S, et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA . 2007; 298(21):2487 – 2496 86. Zalmanovici A, Yaphe J. Intranasal ste- roids for acute sinusitis. Cochrane Data- base Syst Rev . 2009;(4):CD005149 87. Yilmaz G, Varan B, Yilmaz T, Gurakan B. Intranasal budesonide spray as an ad- junct to oral antibiotic therapy for acute sinusitis in children. Eur Arch Oto- rhinolaryngol . 2000;257(5):256 – 259 88. Barlan IB, Erkan E, Bakir M, Berrak S, Basaran MM. Intranasal budesonide spray as an adjunct to oral antibiotic therapy for acute sinusitis in children. Ann Allergy Asthma Immunol . 1997;78(6):598 – 601 89. Bruni FM, De Luca G, Venturoli V, Boner AL. Intranasal corticosteroids and adrenal sup- pression. Neuroimmunomodulation . 2009;16 (5):353 – 362 90. Kim KT, Rabinovitch N, Uryniak T, Simpson B, O ’ Dowd L, Casty F. Effect of budesonide aqueous nasal spray on hypothalamic- pituitary-adrenal axis function in chil- dren with allergic rhinitis. Ann Allergy Asthma Immunol . 2004;93(1):61 – 67 91. Meltzer EO, Tripathy I, Maspero JF, Wu W, Philpot E. Safety and tolerability of fl utica- sone furoate nasal spray once daily in pae- diatric patients aged 6-11 years with allergic rhinitis: subanalysis of three randomized, double-blind, placebo-controlled, multicentre studies. Clin Drug Investig . 2009;29(2):79 – 86 92. Murphy K, Uryniak T, Simpson B, O ’ Dowd L. Growth velocity in children with perennial allergic rhinitis treated with budesonide aqueous nasal spray. Ann Allergy Asthma Immunol . 2006;96(5):723 – 730 93. Ratner PH, Meltzer EO, Teper A. Mometa- sone furoate nasal spray is safe and ef- fective for 1-year treatment of children with perennial allergic rhinitis. Int J Pediatr Otorhinolaryngol . 2009;73(5):651 – 657 94. Skoner DP, Gentile DA, Doyle WJ. Effect on growth of long-term treatment with in- tranasal triamcinolone acetonide aque- ous in children with allergic rhinitis. Ann

FROM THE AMERICAN ACADEMY OF PEDIATRICS

114